APA (7th ed.) Citation

Mackey, J. R., Pieńkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., . . . Eiermann, W. (2016). Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial. Annals of Oncology, 27(6), 1041. https://doi.org/10.1093/annonc/mdw098

Chicago Style (17th ed.) Citation

Mackey, J. R., et al. "Long-term Outcomes After Adjuvant Treatment of Sequential Versus Combination Docetaxel with Doxorubicin and Cyclophosphamide in Node-positive Breast Cancer: BCIRG-005 Randomized Trial." Annals of Oncology 27, no. 6 (2016): 1041. https://doi.org/10.1093/annonc/mdw098.

MLA (9th ed.) Citation

Mackey, J. R., et al. "Long-term Outcomes After Adjuvant Treatment of Sequential Versus Combination Docetaxel with Doxorubicin and Cyclophosphamide in Node-positive Breast Cancer: BCIRG-005 Randomized Trial." Annals of Oncology, vol. 27, no. 6, 2016, p. 1041, https://doi.org/10.1093/annonc/mdw098.